SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals and Industries informs about post offer status

30 Nov 2015 Evaluate

Arihant Capital Markets (‘Manager to the Offer’) on behalf of Ipca Laboratories (‘Acquirer’) has informed about this Post Offer Public Announcement to the shareholders of Krebs Biochemicals and Industries (‘Target Company’), pursuant to Regulation 18 (12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011, as amended (SEBI SAST Regulations) In respect of Open Offer to acquire up to 35,73,515 Equity Shares, constituting 26% of the fully diluted voting Equity Share Capital (the ‘Offer’) of Target Company. The Detailed Public Statement (‘DPS) with respect to the aforementioned Offer was published on February 24, 2015.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

60.90 -0.12 (-0.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×